Enforcement Trends: CMS Looks to Recover $66.3 Million in Improper Specimen Validity Test Payments

Enforcement Trends: CMS Looks to Recover $66.3 Million in Improper Specimen Validity Test Payments

From - National Intelligence Report
The opioid crackdown has made urine drug testing an even greater priority for federal health fraud enforcers. One principle target is specimen validity testing…


. . . read more

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here